Characteristics of Patients with COVID-19 Pneumonia Treated with High-flow Oxygen and Non-invasive Ventilation Outside the Intensive Care Unit

Basit Öğe Kaydı
dc.authoridOzdemir, Levent/0000-0002-3478-5454
dc.contributor.authorOzdemir, Burcu
dc.contributor.authorOzdemir, Levent
dc.contributor.authorCelik, Mehmet Murat
dc.contributor.authorUrfali, Senem
dc.contributor.authorOzdemir, Uyesi Burcu
dc.date.accessioned2024-09-18T20:13:27Z
dc.date.available2024-09-18T20:13:27Z
dc.date.issued2023
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractObjective: Comparing high-flow oxygen (HFO) and non-invasive ventilation (NIV) treatment methods applied to patients hospitalized in the coronavirus disease-2019 (COVID-19) service outside the intensive care unit. Materials and Methods: Demographic characteristics, duration of hospitalization and application times, acute phase reactants, ROX index, comorbid conditions, radiological scores and results were evaluated retrospectively in patients treated with HFO (n=26) and NIV (n=23) who were hospitalized in the COVID service outside the intensive care unit of the state hospital between November 2020 and June 2021. Results: A total of 49 patients, 27 males and 22 females, were included in the study. The mean age was 55.6 +/- 14.6 years. The most common comorbidities were hypertension (n=27), diabetes (n=15). Patients in the HFO group were hospitalized for 16.6 +/- 9.4 days, HFO was applied for 6 +/- 4.6 days. Patients in the NIV group were hospitalized for 9.4 +/- 6.4 days, NIV was applied for 5.8 +/- 4.2 days. The saturation of the patients who were administered HFO (84.1 +/- 4.6) were found to be lower than those who received NIV (88.7 +/- 2). It was determined that 18.37% of 49 patients e.g. 5 of whom were treated with HFO and 4 of them were those who received NIV treatment. The ROX index was found to be significantly lower in the death group (n=9) compared to the survivors (n=40). In radiological imaging, there was no significant difference in the severity of pneumonia in patients treated with HFO and NIV. Lactate dehydrogenase and C-reactive protein from acute phase reactants at the time of hospitalization were significantly higher in the group who ex. Conclusion: It was determined that HFO or NIV was not different in terms of mortality in thr non-intensive care COVID service.en_US
dc.identifier.doi10.4274/tybd.galenos.2022.98700
dc.identifier.endpage201en_US
dc.identifier.issn2602-2974
dc.identifier.issue3en_US
dc.identifier.startpage196en_US
dc.identifier.trdizinid1257438en_US
dc.identifier.urihttps://doi.org/10.4274/tybd.galenos.2022.98700
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1257438
dc.identifier.urihttps://hdl.handle.net/20.500.12483/9193
dc.identifier.volume21en_US
dc.identifier.wosWOS:001124029600006en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isotren_US
dc.publisherGalenos Publ Houseen_US
dc.relation.ispartofTurkish Journal of Intensive Care-Turk Yogun Bakim Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjecthigh-flow oxygenen_US
dc.subjectnon-invasive ventilationen_US
dc.titleCharacteristics of Patients with COVID-19 Pneumonia Treated with High-flow Oxygen and Non-invasive Ventilation Outside the Intensive Care Uniten_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
296.52 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu